Taro-Irbesartan 300 mg (Irbesartan TABLET) 300 MG

Taro-Irbesartan 300 mg tablets are a medication used to manage high blood pressure. This oral tablet contains the active ingredient irbesartan, an angiotensin II receptor blocker (ARB).

Strength

300 MG

Manufacturer / TM Owner

SUN PHARMA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Taro-Irbesartan 300 mg tablets are primarily used for the treatment of high blood pressure, also known as hypertension. Irbesartan works by relaxing blood vessels, making it easier for the heart to pump blood throughout the body. This medication may also be used to reduce the risk of stroke in patients with high blood pressure and left ventricular hypertrophy.

Side Effects

Common effects of Taro-Irbesartan 300 mg tablets may include dizziness, fatigue, and low blood pressure. Some users might experience headaches, nausea, or diarrhea. These effects vary and are not experienced by everyone who takes the medication.

Precautions & Warnings

It is important to use Taro-Irbesartan 300 mg tablets as directed by a healthcare professional. Patients with kidney disease, liver disease, or a history of angioedema should inform their doctor before starting this medication. Regular monitoring of blood pressure is recommended.

Avoid Interactions

Taro-Irbesartan 300 mg tablets may interact with other medications, including diuretics, ACE inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated, as it can enhance the blood pressure-lowering effects of irbesartan. Always consult a healthcare provider before combining medications.

Frequently Asked Questions

Taro-Irbesartan 300 mg tablets are used to manage high blood pressure and reduce the risk of stroke in certain patients.

Taro-Irbesartan 300 mg tablets are taken orally, typically once daily, with or without food. Follow the instructions provided by your healthcare professional.

Common side effects may include dizziness, fatigue, and low blood pressure. Some users might experience headaches, nausea, or diarrhea.

Taro-Irbesartan 300 mg may interact with other medications, including diuretics and NSAIDs. Consult a healthcare provider before combining medications.

Patients with kidney disease, liver disease, or a history of angioedema should inform their doctor before starting Taro-Irbesartan 300 mg.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.